Results 121 to 130 of about 3,945,300 (210)

Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives. [PDF]

Front Immunol
Wen Z, Yu M, Li S, Zeng F, Li J, Li J, Liang G, Wang K.   +7 more
europepmc   +1 more source

Genetic Bone Diseases: A Scoping Review of Pathology, Symptoms, Diagnosis, Treatment, and New Horizons. [PDF]

Adv Genet (Hoboken)
Jones C, Jayasuriya AC.
europepmc   +1 more source

Correction: Immune cell senescence and chronic bone diseases: osteoimmune mechanisms and therapeutic perspectives. [PDF]

Front Immunol
Wen Z, Yu M, Li S, Zeng F, Li J, Li J, Liang G, Wang K.   +7 more
europepmc   +1 more source

A Dialogic Participatory Model Between Professionals and Patients for the Co-Creation of Transitioning Care Management Programmes in Rare Bone Diseases. [PDF]

Health Expect
Mordenti M, Forni S, Grippa E, Forgia MC, Scognamiglio D, Boarini M, Massa G, Romeo A, Sergi A, Sangiorgi L, Transitioning Care Management Working Group (TCM WG).   +10 more
europepmc   +1 more source

Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases. [PDF]

Front Bioeng Biotechnol
Yin G, Wang H, Liu Y, Wang Z, Lin X, Cheng Q, Gao H.   +6 more
europepmc   +1 more source

Bibliometric and visualized analysis of metal‒organic frameworks in bone tissue engineering and bone diseases. [PDF]

Discov Nano
Xia K, Yu L, Qin J, Zhu M, Fan M, Qian W.   +5 more
europepmc   +1 more source

The functional roles and mechanisms of polyamines in age-related bone diseases. [PDF]

Cell Mol Life Sci
Zhang J, Cai C, Zhang Y, Luo C, Huo S, Wang K, Shi C, Liu J, Xu G.   +8 more
europepmc   +1 more source

Endocrine-disrupting chemicals in metabolic bone diseases, including osteoporosis. [PDF]

Turk J Med Sci
Gündüz B, Kiliç Kan E, Atmaca A.
europepmc   +1 more source

Current advances of bone homeostasis imbalance in the cause of hereditary metabolic bone diseases. [PDF]

EFORT Open Rev
Dai X, Wang Y, Huang X, Meng Z, Zheng P.
europepmc   +1 more source

Microneedle-based transdermal delivery systems for metabolic bone diseases: advances, challenges, and future perspectives. [PDF]

Front Bioeng Biotechnol
Xie X, Zheng X, Li D, Zhou Q, Liu Q, Liu M, Wang H, Liu N, Zhu Y, Zhao Y, Gao Y.   +10 more
europepmc   +1 more source